Endoscopic Vessel Harvesting Market Size, Share & Trends Analysis | Global | 2026-2032

Global Endoscopic Vessel Harvesting Device Market Report to 2032

The global endoscopic vessel harvesting device market was valued at $350.9 million in 2025. It is expected to decrease at a compound annual growth rate (CAGR) of -0.7%, reaching $335 million by 2032.

This report covers the global market for endoscopic vessel harvesting (EVH) devices, including devices used in minimally invasive endoscopy procedures as part of coronary artery bypass grafting.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market demand is supported by the clinical benefits of EVH and increasing penetration of endoscopic harvesting methods. However, declining CABG procedure volumes and price competition are expected to drive a modest decrease in overall market value.

Market Overview

The global endoscopic vessel harvesting device market includes products used to harvest vessels for coronary artery bypass grafting procedures through a minimally invasive endoscopic approach.

EVH devices allow surgeons to harvest the saphenous vein or other target vessels through smaller incisions compared with open vessel harvesting. This can reduce trauma at the harvest site and support faster patient recovery.

The global volume of coronary artery bypass grafting procedures has declined in recent years as less invasive catheter-based alternatives continue to gain adoption. Transcatheter aortic valve replacement and other catheter-based treatments offer shorter recovery times and reduced surgical trauma, which has shifted treatment patterns away from some open cardiac procedures.

Despite this pressure, CABG remains clinically necessary for complex, multivessel coronary disease. This preserves a stable base of procedures that continue to require vessel harvesting technologies, helping limit the decline of the EVH device market through 2032.

Market Drivers

Clinical Benefits

EVH devices support minimally invasive vessel harvesting by allowing the necessary vessel to be removed through a smaller incision. This reduces trauma at the harvest site compared with open vessel harvesting.

The clinical benefits include reduced scarring, faster recovery, and improved patient satisfaction. These advantages are important because the harvest site can be a major source of discomfort and complications after CABG procedures.

Open vessel harvesting requires a larger incision and is associated with higher risk of wound complications, including dehiscence, hematoma, and infection. By reducing these risks, EVH devices improve patient outcomes and help maintain demand for endoscopic harvesting methods.

Increasing Penetration

EVH penetration is already very high. In 2025, more than 90% of vessel harvesting procedures used the EVH method.

This penetration is expected to continue rising over the forecast period and approach 100%. Physicians continue to prefer EVH because of its short-term and long-term benefits for patients.

Increasing penetration will help support the market even as CABG procedures decline. While total procedural volume may decrease, higher EVH use within the remaining CABG procedure base helps slow the decline of the EVH device market.

Support for Minimally Invasive CABG

The growing adoption of minimally invasive and robotic coronary artery bypass procedures is increasing demand for advanced EVH devices. These procedures place greater emphasis on tools that support limited access and efficient vessel preparation.

Minimally invasive direct CABG and robotic-assisted approaches require precise and reliable device performance. EVH systems that improve visibility, dissection, cautery, and branch ligation can support these more advanced surgical workflows.

Manufacturers are responding by improving device design, ease of use, and procedural efficiency. These product refinements help support continued innovation in the EVH segment, even as broader CABG procedure growth remains limited.

Market Limiters

Declining CABG Procedures

Declining CABG procedure volume is the main limiter for the EVH device market. EVH devices are used only in CABG procedures, which means the market is closely tied to surgical revascularization volumes.

As less invasive catheter-based alternatives continue to gain adoption, the number of CABG procedures performed is expected to decline. This directly limits demand for vessel harvesting devices.

Although EVH devices are expected to decline more slowly than open harvesting methods, the overall market remains constrained by the CABG procedure base. Unless aging population effects are strong enough to reverse current CABG trends, EVH device demand will remain limited.

Competition

Competition is another major limiter in the EVH device market. In developed markets, companies compete heavily on price.

The entry of new players in the United States and Europe, combined with continued competition between established companies, is expected to drive a steady decrease in ASPs.

This ASP pressure will depress market value over the forecast period. Even if EVH penetration increases, lower pricing can offset some of the revenue benefit created by higher usage.

Procedure Mix Pressure

The EVH market is also limited by broader changes in cardiovascular treatment patterns. As catheter-based interventions continue to expand, some patients who might have previously undergone CABG may be treated through less invasive approaches.

This affects EVH because the device is tied to surgical bypass procedures rather than catheter-based treatment. Even strong EVH penetration cannot fully offset a shrinking CABG procedure base.

As treatment pathways continue to shift toward less invasive alternatives where appropriate, EVH suppliers must focus on the remaining surgical patient population, including complex and multivessel disease cases where CABG remains clinically necessary.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
• Device scope: The report covers endoscopic vessel harvesting devices used in minimally invasive harvesting procedures performed as part of coronary artery bypass grafting.

Markets Covered and Segmentation

Endoscopic Vessel Harvesting Device Market

The report covers the global endoscopic vessel harvesting device market as a dedicated cardiac surgery device segment.

Endoscopic vessel harvesting devices are used during CABG procedures to harvest vessels through a minimally invasive endoscopic approach. These devices help reduce the incision size required for vessel removal and support improved outcomes at the harvest site.

The market is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

The report evaluates EVH demand based on CABG procedure volume, physician adoption, EVH penetration, competitive pricing, product innovation, and the shift toward minimally invasive surgical techniques.

This structure helps manufacturers, investors, and strategy teams understand how CABG trends, vessel harvesting preferences, device pricing, and competitive dynamics are shaping the global EVH market.

Competitive Analysis

Getinge was the leading competitor in the global EVH device market in 2025, dominating the segment with its VASOVIEW(TM) platform.

The company further strengthened its position with the launch of the next-generation VASOVIEW(TM) Hemopro 3 in 2024. This product introduced design and performance enhancements aimed at improving procedural efficiency in minimally invasive CABG procedures.

Supported by its strong installed base and continued product innovation, Getinge is expected to maintain its market share over the coming years.

Terumo was the second-leading competitor in the global EVH device market in 2025. The company offers the VirtuoSaph(TM) and VirtuoSaph(TM) Plus EVH systems.

Terumo is expected to grow its share of the market over the coming years across global regions. Its continued presence in cardiovascular and surgical device markets supports its ability to compete in the EVH segment.

Zimmer Biomet held the third-leading position in the global EVH device market in 2025. The company participates through its Venapax(R) Endoscopic Vessel Harvesting System, which is designed to simplify vessel harvesting by integrating dissection, cautery, and branch ligation into a single device. Although EVH is a relatively small part of Zimmer Biomet's broader portfolio, Venapax supports minimally invasive CABG techniques and positions the company as a key competitor.

Technology and Practice Trends

Minimally Invasive Vessel Harvesting

Minimally invasive vessel harvesting remains the core trend in the EVH market. EVH devices reduce the need for large incisions and support better harvest-site outcomes.

This trend is expected to continue as physicians prioritize recovery, patient satisfaction, and reduced wound complications.

High EVH Penetration

EVH penetration already exceeds 90% of vessel harvesting procedures and is expected to approach 100% over the forecast period.

This high penetration supports continued device demand, even as overall CABG volumes decline.

Integration of Surgical Functions

Some EVH systems integrate multiple functions into a single device, including dissection, cautery, and branch ligation.

This can simplify the vessel harvesting workflow and support procedural efficiency during CABG.

Product Innovation in Mature Markets

EVH is a mature market, but product refinements continue. Manufacturers are improving visibility, ease of use, device control, and procedural efficiency.

These improvements are important for maintaining competitive positioning as ASP pressure continues.

Robotic and Minimally Invasive CABG

Robotic-assisted and minimally invasive CABG procedures are increasing demand for tools that perform well through limited access.

EVH devices that support constrained operative fields may benefit from this procedural shift.

Pressure from Catheter-Based Alternatives

Less invasive catheter-based alternatives are reducing the number of patients undergoing CABG. This creates pressure on all CABG-related device markets, including EVH.

The remaining CABG population is expected to include complex and multivessel disease patients who still require surgical revascularization.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global endoscopic vessel harvesting device market today, and how is it expected to change through 2032?
• How are unit sales, procedure numbers, ASPs, and market values changing over time?
• Why is the EVH market expected to decline despite high penetration?
• What role do EVH devices play in CABG procedures?
• How do EVH devices reduce harvest-site trauma, scarring, and wound complications?
• How is the decline in CABG procedure volume affecting EVH device demand?
• What impact does competition have on ASPs and market value?
• How are minimally invasive and robotic CABG procedures influencing EVH product design?
• Which companies lead the global EVH device market?
• How are Getinge, Terumo, and Zimmer Biomet positioned in the competitive landscape?

The Global Endoscopic Vessel Harvesting Device Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand CABG-related device trends, and support commercial planning in the global EVH device market.